Back to the High-tech Future: IVAM Hightech Summit shows science fiction of yesterday with microtechnology of tomorrow

As a leading conference for the microtechnology industry, the IVAM Hightech Summit offers a unique platform for experts and deciders to exchange information on the latest developments in microtechnology and related fields. Under this year’s theme „Back to the Microtechnology Future: Yesterday’s Visions, Tomorrow’s Realities“, the conference will take place on May 7 and 8 in Frankfurt a. Main, DE.

The IVAM Hightech Summit, a leading conference for the microtechnology industry, takes place on May 7th-8th in Frankfurt. It’s a unique event where experts discuss the latest microtechnology advancements under this year’s theme „Back to the Microtechnology Future: Yesterday’s Visions, Tomorrow’s Realities“. For more details check out their press release at http://idw-online.de/de/news830024.

Originamitteilung:

As a leading conference for the microtechnology industry, the IVAM Hightech Summit offers a unique platform for experts and deciders to exchange information on the latest developments in microtechnology and related fields. Under this year’s theme „Back to the Microtechnology Future: Yesterday’s Visions, Tomorrow’s Realities“, the conference will take place on May 7 and 8 in Frankfurt a. Main, DE.

share this recipe:
Facebook
Twitter
Pinterest

Weitere spannende Artikel

Bioreactor Allows Automated Long-Term Culturing of Stem Cells

Human induced pluripotent stem cells (hiPSCs) are considered as a promising tool in medicine, with the potential to unlock treatments for many health conditions such as neurodegenerative diseases and disorders. However, producing large amounts of hiPSCs remains a challenge. Researchers from the Fraunhofer Translational Center for Regenerative Therapies TLC-RT at the Fraunhofer Institute for Silicate Research ISC have now developed a bioreactor that can be used for automated long-term culturing of hiPSCs.

Read More

Bioreaktor ermöglicht automatisierte Langzeitkultivierung von Stammzellen

Humane induzierte pluripotente Stammzellen (hiPSCs) gelten als vielversprechendes Werkzeug in der Medizin: Künftig sollen sie die Therapie von vielen Leiden wie etwa neurodegenerativen Erkrankungen ermöglichen. Nach wie vor ist jedoch die Herstellung großer Mengen an hiPSCs eine Herausforderung. Forschende des Fraunhofer-Translationszentrums für Regenerative Therapien TLZ-RT am Fraunhofer-Institut für Silicatforschung ISC haben nun einen Bioreaktor entwickelt, mit dem eine automatisierte Langzeitkultivierung von hiPSCs gelingt.

Read More